KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得 入排置信度 0.98

Effects of aprocitentan on prognostically relevant ambulatory blood pressure-derived variables in resistant hypertension.

Markus P Schlaich, Michael A Weber, John M Flack, Parisa Danaietash, Mouna Sassi-Sayadi, Krzysztof Narkiewicz, Ji-Guang Wang

J Hypertens 44(1) 180-188

PMID41195725
PMCIDPMC12672029
DOI10.1097/HJH.0000000000004174
发表日期2025-11-06
入排依据:未发现恶性肿瘤人群证据。
疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 3 张 PMC Figure,均未识别为 KM 图:FIGURE 1:森林图/亚组分析图;FIGURE 2:非 KM 图;FIGURE 3:AI 判定为 other。
摘要

摘要

BACKGROUND: Ambulatory blood pressure measurement (ABPM) data from the PRECISION study have shown that in patients with confirmed resistant hypertension (RHT), aprocitentan leads to substantial lowering of BP, particularly at night-time. Here, the ABPM data were used to define subgroups with substantial prognostic value (dipping pattern, BP load, heart rate, arterial stiffness, and salt sensitivity) and to evaluate the BP-lowering effect of aprocitentan on these subgroups. METHODS: The effects of aprocitentan on ABPM derivatives including dipping pattern, BP load, and heart rate were evaluated. The BP lowering effect of aprocitentan was assessed based on the subject's baseline arterial stiffness and salt sensitivity. RESULTS: At week 4, the placebo-corrected and dose-dependent decrease of ambulatory systolic BP was more marked for baseline non-dippers than dippers. The proportion of non-dippers at baseline whose dipping pattern normalized at week 4 was higher for the aprocitentan group compared to placebo. The decrease in BP load during daytime/nighttime was also more pronounced with aprocitentan compared to placebo. Despite the BP lowering effect of aprocitentan, heart rate remained unchanged at week 36. The BP lowering effect of aprocitentan was not diminished by increased arterial stiffness index or salt sensitivity risk at baseline. CONCLUSION: In addition to a significant and sustained day and night-time ambulatory BP reduction, aprocitentan was associated with a higher proportion of patients experiencing dipping pattern normalization and more pronounced BP load reduction, indicating prognostic relevance. Increased arterial stiffness or salt sensitivity did not alter the BP response to aprocitentan, suggesting additional clinical benefit.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(3,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

FIGURE 1Forest plot: least square mean differences from placebo in SBP changes at week 4 and 95% confidence interval (overall and by subgroup). CI, confidence interval; LSM, least square mean.
非 KM Figure
FIGURE 2Least square mean changes in 24-h, daytime and night-time ambulatory SBP from baseline to week 4 during part 1. Least square mean differences from placebo are reported with 95% confidence intervals. Bars are standard error of the mean.
非 KM Figure
FIGURE 3Least square mean changes in daytime and night-time blood pressure load from baseline to week 4 during part 1. Least square mean differences from placebo are reported with 95% confidence intervals. Bars are standard error of the mean. BP, blood pressure.
非 KM Figure